Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
cyt-0851 (1 trial)
Leiomyosarcoma (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Mantle-Cell (Phase 2)
Multiple Myeloma (Phase 2)
Neoplasms (Phase 2)
Sarcoma (Phase 2)
Trials (1 total)
Trial APIs (1 total)